Survival Rate for HER2-Positive Breast Cancer

The type of breast cancer that has a little chance of survival is the HER2-positive breast cancer. The HER2 positive breast cancer survival rate of the patients that have this HER2-positive breast cancer is likely smaller than those patients that are HER2-negative. The HER2 positive breast cancer survival rate of person that has HER2 positive breast cancer depends on the number of cancerous cells in the breast tissue, risk factors such as initial treatment, age and general health, location, size and stage of the breast tumor. However, the risk and a chance of cancer recurrence can be decreased by the treatments that will be given by the expert.

HER2 Positive Breast Cancer Survival Rate Prognosis

1.            The HER2 positive breast cancer survival rate in patients that are in the early stage can be cured after some tests.

2.            The HER2 positive breast cancer survival rate for women that have advanced stage of HER2-Positive is likely 27 percent for five years.

3.            The HER2 positive breast cancer survival rate for African-American patients is lesser than Caucasian patients for the reason of late stage detection.

4.            Patients with a greater risk of recurrence or death are those with HER2-positive breast cancer.

HER2 Positive Breast Cancer Survival Rate for HE2-Positive Patients

Patients that have HER2-positive breast cancer have a chance of recurrence 2 – 5 times than those patients that have a HER2-negative breast cancer. The HER2-positive breast cancer tumor is quite unusual in patients that are in the early stage and small breast cancers with 7 to 10% of occurrence. Moreover, successful treatments for women who have an early stage of breast cancer are probable to have risks of cancer recurrence than those diagnosed on the later stage. The HER2 positive breast cancer survival rate for early stage is greater than those diagnosed on the later stage. Thus, patients need to take medical drugs in order to increase the HER2 positive breast cancer survival rate. There is a drug that can help reduce the risk of cancer recurrence and that is the Trastuzumab drug.

her2 positive breast cancer survival rate

Trastuzumab Drug for Increasing HER2 Positive Breast Cancer Survival Rate

In increasing the HER2 positive breast cancer survival rate, the Trastuzumab drug can be a vital drug to control and destroy the recurrence of cancerous cells after the initial treatment. The Trastuzumab is a drug that targets the HER2-protein and gene in order to stop the rapid growth of breast cancer cells. The HER2 positive breast cancer survival rate upon trying the Trastuzumab drug reduces the risk and chance of recurrence of cancer cells for the next surgery or treatment. The Trastuzumab is FDA-approved for treating HER2 positive breast cancer and for those patients with the node-negative ailment with hormone receptor-positive tumors. The Trastuzumab is also used for chemotherapy treatment for increasing the HER2 positive breast cancer survival rate. The drug serves as treatment for those women with small breast tumor that has not yet spread to the lymph nodes. The usage of this drug on increasing the HER2 positive breast cancer survival rate is a significant thing for curing breast cancer.

Like it.? Share it: